Cgic2024 Day 1 Session: Characterizing Conditions With A Drug Development Mindset

CGIC2024 Day 1 Session: Characterizing Conditions with a Drug Development Mindset

Critical Path Institute

CGIC2024 Day 3: Opening Remarks & Session 1: Evidentiary Considerations for Drug Development Tools

Critical Path Institute

CGIC2024 Day 1: Transformative Tools to Capture Early Stages of Disease

Critical Path Institute

CGIC2024 Day 2: A Potential New Framework to Advancing Drug Development

Critical Path Institute

CGIC2024 Day 3: Patient-Focused Drug Development in the Age of Cell and Gene-Based Therapies

Critical Path Institute

CGIC2024 Day 1: Navigating the PFDD Roadmap: Update on the RD-COA Resource

Critical Path Institute

CGIC2024 Day 3: Leveraging Learnings for the Future of Drug Development

Critical Path Institute

CGIC2024 Day 1 Fireside Chat: Maximizing the Impact of CDER-led Efforts

Critical Path Institute

CGIC2024 Day 2 Opening Remarks & Session 1: From Data to Knowledge.

Critical Path Institute

Advancing Generic Drug Development: Translating Science to Approval 2023 – Day 1 – Part 1

U.S. Food and Drug Administration

CGIC2024 Day 2: Applying Learnings to New Frontiers

Critical Path Institute

Advancing Generic Drug Development: Translating Science to Approval - Day 1 – Keynote and Session 1

U.S. Food and Drug Administration

CGIC2024 Day 1: AI Algorithm Literacy

Critical Path Institute

Advancing Generic Drug Development: Translating Science to Approval 2024 – Day 1 – Part 2

U.S. Food and Drug Administration

CGIC2024 Day 3: Transforming Translational Sciences: From Biomarkers to New Approach Methodologies

Critical Path Institute

New Horizons in Pediatric Drug Development - Day 1, Session 2, Part 1

Robert Lustig, MD: Group A Strep Grows Better with Fructose Than Glucose

Richard Johnson, MD: How Does the Body Make Fructose?

Robert Lustig, MD: Ketones Do Not Need Insulin to Work

Robert Lustig, MD: What are Emulsifiers?